Inventor
GILLINGS MIREILLE
US11 patents
⚠️ This page may combine multiple inventors who share the name “GILLINGS MIREILLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HUYABIO INT LLC
7 patentsUS11813245B2Nov 14, 2023
Sulcardine administration for treatment of acute atrial fibrillation
HUYABIO INT LLC2 citations65
US12122833B2Oct 22, 2024
Combination therapies of HDAC inhibitors and PD-1 inhibitors
HUYABIO INT LLC0 citations60
US11535670B2Dec 27, 2022
Combination therapies of HDAC inhibitors and PD-L1 inhibitors
HUYABIO INT LLC1 citations60
US12390469B2Aug 19, 2025
SHP2 inhibitor monotherapy and uses thereof
HUYABIO INT LLC0 citations56
US12097203B2Sep 24, 2024
Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors
HUYABIO INT LLC1 citations56
US12465587B2Nov 11, 2025
Sulcardine administration for treatment of acute atrial fibrillation
HUYABIO INT LLC0 citations55
US11426382B2Aug 30, 2022
Sulcardine salts
HUYABIO INT LLC0 citations55
HUYA BIOSCIENCE INT LLC
4 patentsUS10385131B2Aug 20, 2019
Combination therapies of HDAC inhibitors and PD-L1 inhibitors
HUYA BIOSCIENCE INT LLC9 citations81
US10287353B2May 14, 2019
Combination therapies of HDAC inhibitors and PD-1 inhibitors
HUYA BIOSCIENCE INT LLC9 citations81
US10385130B2Aug 20, 2019
Combination therapies of HDAC inhibitors and PD-1 inhibitors
HUYA BIOSCIENCE INT LLC2 citations70
US11020374B2Jun 1, 2021
Sulcardine salts
HUYA BIOSCIENCE INT LLC4 citations65